Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 193
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01813370 | A Registry for Patients Treated on the Clinical Trial TAX 3503 | ||
| NCT00248482 | Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT02178436 | Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | ||
| NCT03421652 | Nivolumab and RT in Treating Patients With Localized/Locally Advanced Urothelial Bladder Cancer Ineligible for Chemo | ||
| NCT00243048 | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | ||
| NCT01888198 | Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | ||
| NCT00897741 | Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer | ||
| NCT04037462 | Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy | ||
| NCT05903092 | MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer | ||
| NCT02568449 | Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent | ||
| NCT00003626 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | ||
| NCT07222306 | Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study | ||
| NCT06576115 | Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer | ||
| NCT00768118 | A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants | ||
| NCT02819024 | Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography | ||
| NCT04397679 | Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma | ||
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | ||
| NCT00011973 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT00016185 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | ||
| NCT00227721 | Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer | ||
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT01612910 | Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery | ||
| NCT00897910 | Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma | ||
| NCT00938626 | Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma | ||
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | ||
| NCT00521261 | Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | ||
| NCT00618826 | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer | ||
| NCT00027807 | Biological Therapy in Treating Women With Stage IV Breast Cancer | ||
| NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | ||
| NCT00268255 | Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | ||
| NCT01022138 | Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer | ||
| NCT03454529 | The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer | ||
| NCT07743086 | Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing | ||
| NCT03252600 | Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis | ||
| NCT01116232 | Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation | ||
| NCT01534143 | High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant | ||
| NCT01728259 | First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD | ||
| NCT01812668 | Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | ||
| NCT03683420 | Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment | ||
| NCT00002907 | Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma | ||
| NCT01205646 | PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | ||
| NCT02663622 | Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002) | ||
| NCT02824029 | Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma | ||
| NCT00906503 | Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules | ||
| NCT06420167 | DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | ||
| NCT02269267 | The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) | ||
| NCT02470559 | Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent | ||
| NCT00238329 | PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma | ||
| NCT07118202 | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | ||
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer |
